Standout Papers

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases 2019 2026 2021 2023 1.2k
  1. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases (2019)
    Kevin R. Flaherty, Athol U. Wells et al. New England Journal of Medicine

Immediate Impact

1 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2025 Standout
Fibrosis in IBD: from pathogenesis to therapeutic targets
2024 Standout
3 intermediate papers

Works of Thomas Haeufel being referenced

Safety and tolerability of spesolimab in patients with ulcerative colitis
2022
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
2019 Standout

Author Peers

Author Last Decade Papers Cites
Thomas Haeufel 118 67 155 1153 502 6 1.3k
Carl Coeck 64 27 210 1426 604 18 1.6k
Anand Devaraj 49 24 183 1429 603 14 1.6k
Rainer-Georg Goeldner 57 21 173 1508 599 13 1.7k
R.M. duBois 120 47 99 937 281 15 1.3k
Roland du Bois 73 23 128 977 704 18 1.2k
P. Pantelidis 87 40 78 844 250 12 1.0k
Martina Gahlemann 155 126 167 1318 508 25 1.6k
Andrew G. Nicholson 174 37 57 1035 1034 21 1.6k
C. Sainte Rose 35 13 85 824 895 15 1.6k
Anna-Luise Katzenstein 27 14 107 784 297 15 1.4k

All Works

Loading papers...

Rankless by CCL
2026